ATX 3 308 0,1%  Dow 24 509 -0,3%  Nasdaq 6 390 -0,1%  Euro 1,1783 0,1% 
ATX P 1 671 0,1%  EStoxx50 3 556 -0,7%  Nikkei 22 519 -0,8%  CHF 1,1649 0,1% 
DAX 13 068 -0,4%  FTSE100 7 448 -0,7%  Öl 63,4 1,0%  Gold 1 254 0,2% 

A&T Aktie [WKN: 121070 / ISIN: JP3160680009]

07.12.2017 22:05:00

Optinose to Present at BMO Capital Markets Prescription for Success Healthcare Conference


YARDLEY, Pa., Dec. 07, 2017 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ENT and allergy specialists, today announced that Chief Executive Officer Peter Miller will present at the BMO Capital Markets 2017 Prescriptions for Success Healthcare Conference December 14, 2017, at 9 am ET in New York. To listen to a webcast of the presentation live, please visit the Investors page of the Optinose website. A replay of the webcast will be available for 90 days following the conclusion of the event.
Weiter zum vollständigen Artikel bei "Globe Newswire (RSS)"

Analysen zu A&T Corp

mehr Analysen
  • Alle
  • Buy
  • Hold
  • Sell

Eintrag hinzufügen

Aktien in diesem Artikel

A&T Corp 941,00 -0,21% A&T Corp
18,81 0,80% OptiNose Inc Registered Shs
6,50 -6,47% Success Holding Group Corp USA

Nachrichten

  • Nachrichten zu Aktien
  • Alle Nachrichten
pagehit